Matthew Bick
Chief Executive Officer at Accipiter Biosciences.
- Seattle, WA
- Form D signer
- Accipiter Biosciences
Raised on Accipiter Biosciences filings
$10.5M
of $10.5M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 1
- Last filing
- Jul 28, 2026
Company
Accipiter Biosciences
Biotech · Seattle, WA
Computationally designed proteins that hit several targets
Computationally designed proteins that hit several targets
- Investors
- 9
- Founded
- 2023
Accipiter Biosciences filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 28, 2026 | Equity | $10.5M/ $10.5M | Form D |
- EquityFiled Jul 28, 2026Form D$10.5M/ $10.5M
